4//SEC Filing
ACCENTIA BIOPHARMACEUTICALS INC 4
Accession 0001181431-12-055667
CIK 0001310094operating
Filed
Oct 25, 8:00 PM ET
Accepted
Oct 26, 4:56 PM ET
Size
5.4 KB
Accession
0001181431-12-055667
Insider Transaction Report
Form 4
ODONNELL FRANCIS E JR
DirectorCHAIRMAN & CEO
Transactions
- Other
Common Stock
2012-10-24−500,000→ 3,335,992 total(indirect: By LLC)
Footnotes (2)
- [F1]The subject shares, which were held indirectly by the reporting person through Hopkins Capital Group, LLC, were involuntarily transferred by Hopkins Capital Group, LLC to a lender of Hopkins Capital Partners, Inc. under a pledge and account control agreement between the lender and Hopkins Capital Partners, Inc. The lender exercised its rights to take title to such shares in exchange for a reduction in Hopkins Capital Partners, Inc.'s secured indebtedness equal to $0.12 per transferred share.
- [F2]The reporting person is the managing partner in Hopkins Capital Group, LLC and disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
ACCENTIA BIOPHARMACEUTICALS INC
CIK 0001310094
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0001310094
Filing Metadata
- Form type
- 4
- Filed
- Oct 25, 8:00 PM ET
- Accepted
- Oct 26, 4:56 PM ET
- Size
- 5.4 KB